NCT01642186 2022-12-29Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)Memorial Sloan Kettering Cancer CenterPhase 2 Completed28 enrolled 13 charts